Identification and Functional Assessment of BCRP Polymorphisms in a Korean Population

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Drug Metabolism And Disposition

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.106.012302PMID 17237154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stem cell marker

  2006cited by this paper
• Functional Validation of the Genetic Polymorphisms of Human ATP-Binding Cassette (ABC) Transporter ABCG2: Identification of Alleles That Are Defective in Porphyrin Transport

  2006cited by this paper
• Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma

  2005cited by this paper
• FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA

  2005influential reference
• Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity

  2005cited by this paper
• Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

  2004cited by this paper
• Functional Analysis of SNPs Variants of BCRP/ABCG2

  2004influential reference
• Linkage Disequilibrium and Haplotype Architecture for two ABC Transporter Genes (ABCC1 and ABCG2) in Chinese Population: Implications for Pharmacogenomic Association Studies

  2004cited by this paper
• The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme*

  2004cited by this paper
• Modulation of Cellular Cholesterol Alters P-Glycoprotein Activity in Multidrug-Resistant Cells

  2004cited by this paper
• Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2

  2004influential reference
• A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.

  2003cited by this paper
• Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

  2003influential reference
• Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population.

  2003cited by this paper
• HIF-1 and tumor progression: pathophysiology and therapeutics.

  2002cited by this paper
• Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.

  2002cited by this paper
• Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1)

  2002cited by this paper
• The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.

  2002cited by this paper
• Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2 Multidrug Transporter

  2002cited by this paper
• The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

  2002cited by this paper
• BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia

  2002cited by this paper
• Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.

  2002cited by this paper
• C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

  2002cited by this paper
• From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

  2001cited by this paper
• Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

  2001cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001cited by this paper
• Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.

  2001cited by this paper
• The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

  2001cited by this paper
• The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).

  2000cited by this paper
• Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

  2000cited by this paper
• Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

  1999cited by this paper
• Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

  1999cited by this paper
• Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

  1999cited by this paper
• Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

  1999cited by this paper
• ABC Transport Genes in Mitoxantrone-resistant Cells : Demonstration of Homology Molecular Cloning of cDNAs Which Are Highly Overexpressed

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998influential reference
• The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target

  1998cited by this paper
• A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

  1998influential reference
• Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection

  1998cited by this paper

• ABCG2 polymorphisms and susceptibility to ARV‐associated hepatotoxicity

  2024cites this paper
• An in-silico analysis predicting the impact of coding single nucleotide polymorphisms (SNPs) in the human multidrug pump ABCG2

  2023cites this paper
• Medically Important Alterations in Transport Function and Trafficking of ABCG2

  2021cites this paper
• Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: A case report and literature review.

  2020cites this paper
• Circadian Clock and Efflux Transporters

  2020cites this paper
• Circadian Pharmacokinetics

  2020cites this paper
• Comprehensive Analysis of ABCG2 Genetic Variation in the Polish Population and Its Inter-Population Comparison

  2020cites this paper
• Identification and functional characterization of CYP4V2 genetic variants exhibiting decreased activity of lauric acid metabolism

  2020cites this paper
• Picky ABCG5/G8 and promiscuous ABCG2 ‐ a tale of fatty diets and drug toxicity

  2020cites this paper
• Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2

  2019cites this paper
• Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.

  2019cites this paper
• Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and 1 rosuvastatin 2

  2019cites this paper
• Effect of multiple‐dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin

  2018cites this paper
• BCRP/ABCG2 and high‐alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications

  2018cites this paper
• Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).

  2018cites this paper
• Polymorphisms of the Multidrug Pump ABCG2: A Systematic Review of Their Effect on Protein Expression, Function, and Drug Pharmacokinetics

  2018influential citation
• Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers

  2017cites this paper
• Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans

  2016cites this paper
• Frequency of ABCG2 421C>A Genetic Variant and The Efficiency ofTreatment with Rosuvastatin in Kazakh Male Patients

  2016cites this paper
• Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model

  2016cites this paper
• Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

  2015cites this paper
• Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis

  2015cites this paper
• Analysis of genetic polymorphism and biochemical characterization of a functionally decreased variant in prostacyclin synthase gene (CYP8A1) in humans.

  2015cites this paper
• Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy

  2015cites this paper
• Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor

  2014cites this paper
• Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.

  2014cites this paper
• Genetic variations in UDP-glucuronosyltransferase 2B15 in a Korean population.

  2014cites this paper
• Breast Cancer Resistance Protein (BCRP) or ABCG2

  2014cites this paper
• Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions.

  2013cites this paper
• Regulation, Function, and Clinical Relevance of ABCG2 in Prostate Cancer

  2013cites this paper
• Computational analysis and predictive modeling of polymorph descriptors

  2013cites this paper
• 14. BCRP (ABCG2)

  2013cites this paper
• GENETIC POLYMORPHISMS OF THE ADENOSINE TRIPHOSPHATE-BINDING CASSETTE TRANSPORTERS(ABCG2, ABCB1) AND GEFITINIB TOXICITY

  2012cites this paper
• ABCG2 null alleles define the Jr(a−) blood group phenotype

  2012cites this paper
• Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior

  2012cites this paper
• Deletion of Abcg2 Has Differential Effects on Excretion and Pharmacokinetics of Probe Substrates in Rats

  2012cites this paper
• Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

  2012cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2012cites this paper
• Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level

  2011cites this paper
• In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).

  2011cites this paper
• Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR−) Rats

  2011cites this paper
• BCRP (ABCG2) expression, function and regulation in model and intestinal epithelial cells

  2011cites this paper
• Response to “Predictable difficulty or difficulty to predict”

  2011cites this paper
• Multi-Drug Resistance in Cancer

  2010cites this paper
• Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent

  2010cites this paper
• ABCG2 Polymorphism Is Associated With the Low‐Density Lipoprotein Cholesterol Response to Rosuvastatin

  2010cites this paper
• Impact of breast cancer resistance protein on cancer treatment outcomes.

  2010cites this paper
• Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population

  2010cites this paper
• Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population.

  2010cites this paper
• SNP Communication Genetic Variations in UDP-glucuronosyltransferase 2 B 7 Gene ( UGT 2 B 7 ) in a Korean Population

  2010cites this paper
• ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations

  2010cites this paper
• Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: substrates and/or inhibitors?

  2009cites this paper
• Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease

  2009cites this paper
• Intracellular trafficking of MDR transporters and relevance of SNPs.

  2009cites this paper
• Identification and characterization of single nucleotide polymorphisms of SLC22A11 (hOAT4) in Korean women osteoporosis patients.

  2008cites this paper
• Quercetin pharmacokinetics in humans

  2008cites this paper
• Molecular pathogenesis of intrahepatic cholestasis of pregnancy

  2008cites this paper
• ABCG2 Q141K polymorphism is associated with chemotherapy‐induced diarrhea in patients with diffuse large B‐cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/ vincristine/prednisone chemotherapy

  2008cites this paper
• The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.

  2008cites this paper
• In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?

  2008cites this paper